The time for next-generation molecular genetic diagnostics in nephrology is now!
Sign Up to like & getrecommendations! Published in 2018 at "Kidney international"
DOI: 10.1016/j.kint.2018.03.025
Abstract: Global and disease-group genetic testing is replacing single-gene molecular diagnostics. Bullich et al. demonstrate that gene panel analysis can result in a high yield of genetic diagnoses in cystic and familial glomerular populations. As the complexity… read more here.
Keywords: nephrology; time next; molecular genetic; genetic diagnostics ... See more keywords
Real-world comparison of time to next treatment for patients with high-risk CLL/SLL in first line of treatment.
Sign Up to like & getrecommendations! Published in 2024 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2024.42.16_suppl.e19027
Abstract: e19027 Background: The International Workshop on CLL recommends testing patients (pts) with CLL/SLL for deletion 17p (del17p) and tumor protein (TP) 53 mutations for prognosis and treatment decisions. Both Bruton Tyrosine Kinase inhibitors (BTKi) and… read more here.
Keywords: time next; treatment; next treatment; high risk ... See more keywords
Time to Next Treatment as a Meaningful Endpoint for Trials of Primary Cutaneous Lymphoma
Sign Up to like & getrecommendations! Published in 2020 at "Cancers"
DOI: 10.3390/cancers12082311
Abstract: Time to next treatment (TTNT) is an emerging endpoint in clinical studies of primary cutaneous T-cell lymphomas (CTCL), with utility as a surrogate marker for the “duration of clinical benefit”. TTNT provides a highly clinically… read more here.
Keywords: endpoint; time next; next treatment; treatment ... See more keywords